Literature DB >> 12529428

Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell.

Achim Temme1, Michael Rieger, Friedemann Reber, Dirk Lindemann, Bernd Weigle, Petra Diestelkoetter-Bachert, Gerhard Ehninger, Masaaki Tatsuka, Yasuhiko Terada, Ernst Peter Rieber.   

Abstract

Survivin, a member of the inhibitor of apoptosis protein family, has attracted growing attention due to its expression in various tumors and its potential application in tumor therapy. However, its subcellular localization and function have remained controversial: Recent studies revealed that survivin is localized at the mitotic spindle, binds caspases, and could thus protect cells from apoptosis. The cell cycle-dependent expression of survivin and its antiapoptotic function led to the hypothesis that survivin connects the cell cycle with apoptosis, thus providing a death switch for the termination of defective mitosis. In other studies, survivin was detected at kinetochores, cleavage furrow, and midbody, localizations being characteristic for chromosomal passenger proteins. These proteins are involved in cytokinesis as inferred from the observation that RNA interference and expression of mutant proteins led to cytokinesis defects without an increase in apoptosis. To remedy these discrepancies, we analyzed the localizations of a survivinDsRed fusion protein in HeLa cells by using confocal laser scanning microscopy and time-lapse video imaging. SurvivinDsRed was excluded from the interphase nucleus and was detected in centrosomes and at kinetochores. It dissociated from chromosomes at the anaphase/telophase transition and accumulated at the ends of polar microtubuli where it was immediately condensed to the midbody. Overexpression of both survivinDsRed and of a phosphorylation-defective mutant conferred resistance against apoptosis-inducing reagents, but only the overexpressed mutant protein caused an aberrant cytokinesis. These data characterize in detail the dynamics of survivin in vertebrate cells and confirm that survivin represents a chromosomal passenger protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529428      PMCID: PMC140229          DOI: 10.1091/mbc.e02-04-0182

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  46 in total

1.  A new perfusion cell chamber system for determination of heat shock effects by means of video-enhanced microscopy.

Authors:  A Hofer; F Nagel; F Wonka; H E Krinke; F Gölfert; R H Funk
Journal:  Med Biol Eng Comput       Date:  1999-09       Impact factor: 2.602

2.  Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin.

Authors:  S W Muchmore; J Chen; C Jakob; D Zakula; E D Matayoshi; W Wu; H Zhang; F Li; S C Ng; D C Altieri
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

3.  Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement.

Authors:  M A Verdecia; H Huang; E Dutil; D A Kaiser; T Hunter; J P Noel
Journal:  Nat Struct Biol       Date:  2000-07

4.  Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.

Authors:  D Grossman; J M McNiff; F Li; D C Altieri
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

5.  Expression of survivin and Bcl-2 in the normal human endometrium.

Authors:  R Konno; H Yamakawa; H Utsunomiya; K Ito; S Sato; A Yajima
Journal:  Mol Hum Reprod       Date:  2000-06       Impact factor: 4.025

6.  Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.

Authors:  C Mahotka; M Wenzel; E Springer; H E Gabbert; C D Gerharz
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

7.  Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions.

Authors:  E M Conway; S Pollefeyt; J Cornelissen; I DeBaere; M Steiner-Mosonyi; K Ong; M Baens; D Collen; A C Schuh
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

8.  Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides.

Authors:  M Schmitz; P Diestelkoetter; B Weigle; F Schmachtenberg; S Stevanovic; D Ockert; H G Rammensee; E P Rieber
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

9.  Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation.

Authors:  K Kobayashi; M Hatano; M Otaki; T Ogasawara; T Tokuhisa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Pleiotropic cell-division defects and apoptosis induced by interference with survivin function.

Authors:  F Li; E J Ackermann; C F Bennett; A L Rothermel; J Plescia; S Tognin; A Villa; P C Marchisio; D C Altieri
Journal:  Nat Cell Biol       Date:  1999-12       Impact factor: 28.824

View more
  23 in total

Review 1.  Chromosomal passengers: the four-dimensional regulation of mitotic events.

Authors:  Paola Vagnarelli; William C Earnshaw
Journal:  Chromosoma       Date:  2004-09-04       Impact factor: 4.316

2.  Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells.

Authors:  De-Jian Dai; Cai-De Lu; Ri-Yong Lai; Jun-Ming Guo; Hua Meng; Wei-Sheng Chen; Jun Gu
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

Review 3.  Induction of apoptosis in lymphoid and myeloid leukemia.

Authors:  Aaron D Schimmer
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

4.  A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment.

Authors:  Galina A Gusarova; I-Ching Wang; Michael L Major; Vladimir V Kalinichenko; Timothy Ackerson; Vladimir Petrovic; Robert H Costa
Journal:  J Clin Invest       Date:  2006-12-14       Impact factor: 14.808

5.  ApoER2 (Apolipoprotein E Receptor-2) Deficiency Accelerates Smooth Muscle Cell Senescence via Cytokinesis Impairment and Promotes Fibrotic Neointima After Vascular Injury.

Authors:  Ravi K Komaravolu; Meaghan D Waltmann; Eddy Konaniah; Anja Jaeschke; David Y Hui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-15       Impact factor: 8.311

6.  Suppressors of Bir1p (Survivin) identify roles for the chromosomal passenger protein Pic1p (INCENP) and the replication initiation factor Psf2p in chromosome segregation.

Authors:  Han-Kuei Huang; Julie M Bailis; Joel D Leverson; Eliana B Gómez; Susan L Forsburg; Tony Hunter
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

7.  Survival benefit with proapoptotic molecular and pathologic responses from dual targeting of mammalian target of rapamycin and epidermal growth factor receptor in a preclinical model of pancreatic neuroendocrine carcinogenesis.

Authors:  Christopher W Chiu; Hiroaki Nozawa; Douglas Hanahan
Journal:  J Clin Oncol       Date:  2010-09-07       Impact factor: 44.544

8.  Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias.

Authors:  Kazuyuki Sugahara; Akiko Uemura; Hitomi Harasawa; Hiroshi Nagai; Yoichi Hirakata; Masao Tomonaga; Kenn Murata; Hiroshi Sohda; Toru Nakagoe; Sin-ichi Shibasaki; Yasuaki Yamada; Shimeru Kamihira
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

9.  3-O-methylfunicone, a metabolite of Penicillium pinophilum, inhibits proliferation of human melanoma cells by causing G(2) + M arrest and inducing apoptosis.

Authors:  A Baroni; A De Luca; A De Filippis; M Petrazzuolo; L Manente; R Nicoletti; M A Tufano; E Buommino
Journal:  Cell Prolif       Date:  2009-05-22       Impact factor: 6.831

10.  A single amino acid change (Asp 53 --> Ala53) converts Survivin from anti-apoptotic to pro-apoptotic.

Authors:  Zhiyin Song; Shixin Liu; He He; Naser Hoti; Yi Wang; Shanshan Feng; Mian Wu
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.